About

Publications While At HealthPartners

selected publications

Journal Article

Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II

2017

A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II

2016

Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI

2016

Elevated TNF-alpha is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI. 

Molecular Genetics and Metabolism. 2016

Mucopolysaccharidosis (MPS) physical symptom score: development, reliability, and validity

2016

Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI. 

Journal of Pediatric Rehabilitation Medicine. 2014

Abstract

TNF-a levels are increased in children with mucopolysaccharidosis types I, II, and VI treated with ERT [abstract]. 

Molecular Genetics and Metabolism. 2014

The MPS health assessment questionnaire: preliminary normative and validity data [abstract]. 

Molecular Genetics and Metabolism. 2014

Contact

full name

C. B. Whitley

Quick Info

 

Collaboration

Co-author network

Map of science